Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy

Christopher A. Eide; Diana Brewer; Tao Xie; Anna Reister Schultz; Samantha L. Savage; Serena Muratcioglu; Noah Merz; Richard D. Press; Thomas O'Hare; Thomas Jacob; Tania Q. Vu; Cristina E. Tognon; Tara A. Macey; John Kuriyan; Charalampos G. Kalodimos; Brian J. Druker

doi:10.1016/j.ccell.2024.08.004

Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy

Christopher A. Eide
, Diana Brewer
, Tao Xie
, Anna Reister Schultz
, Samantha L. Savage
, Serena Muratcioglu
, Noah Merz
, Richard D. Press
, Thomas O'Hare
, Thomas Jacob
, Tania Q. Vu
, Cristina E. Tognon
, Tara A. Macey
, John Kuriyan
, Charalampos G. Kalodimos
, Brian J. Druker

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1486-1488
Number of pages	3
Journal	Cancer Cell
Volume	42
Issue number	9
DOIs	https://doi.org/10.1016/j.ccell.2024.08.004
State	Published - Sep 9 2024

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.ccell.2024.08.004

Cite this

Eide, C. A., Brewer, D., Xie, T., Schultz, A. R., Savage, S. L., Muratcioglu, S., Merz, N., Press, R. D., O'Hare, T., Jacob, T., Vu, T. Q., Tognon, C. E., Macey, T. A., Kuriyan, J., Kalodimos, C. G., & Druker, B. J. (2024). Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy. Cancer Cell, 42(9), 1486-1488. https://doi.org/10.1016/j.ccell.2024.08.004

Eide, CA, Brewer, D, Xie, T, Schultz, AR, Savage, SL, Muratcioglu, S, Merz, N, Press, RD, O'Hare, T, Jacob, T, Vu, TQ , Tognon, CE, Macey, TA, Kuriyan, J, Kalodimos, CG & Druker, BJ 2024, 'Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy', Cancer Cell, vol. 42, no. 9, pp. 1486-1488. https://doi.org/10.1016/j.ccell.2024.08.004

@article{4b0e1be06d6d480d924b57e0df03f32b,

title = "Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy",

author = "Eide, \{Christopher A.\} and Diana Brewer and Tao Xie and Schultz, \{Anna Reister\} and Savage, \{Samantha L.\} and Serena Muratcioglu and Noah Merz and Press, \{Richard D.\} and Thomas O'Hare and Thomas Jacob and Vu, \{Tania Q.\} and Tognon, \{Cristina E.\} and Macey, \{Tara A.\} and John Kuriyan and Kalodimos, \{Charalampos G.\} and Druker, \{Brian J.\}",

year = "2024",

month = sep,

day = "9",

doi = "10.1016/j.ccell.2024.08.004",

language = "English (US)",

volume = "42",

pages = "1486--1488",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "9",

}

TY - JOUR

T1 - Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy

AU - Eide, Christopher A.

AU - Brewer, Diana

AU - Xie, Tao

AU - Schultz, Anna Reister

AU - Savage, Samantha L.

AU - Muratcioglu, Serena

AU - Merz, Noah

AU - Press, Richard D.

AU - O'Hare, Thomas

AU - Jacob, Thomas

AU - Vu, Tania Q.

AU - Tognon, Cristina E.

AU - Macey, Tara A.

AU - Kuriyan, John

AU - Kalodimos, Charalampos G.

AU - Druker, Brian J.

PY - 2024/9/9

Y1 - 2024/9/9

UR - https://www.scopus.com/pages/publications/85203870632

UR - https://www.scopus.com/pages/publications/85203870632#tab=citedBy

U2 - 10.1016/j.ccell.2024.08.004

DO - 10.1016/j.ccell.2024.08.004

M3 - Letter

C2 - 39214096

AN - SCOPUS:85203870632

SN - 1535-6108

VL - 42

SP - 1486

EP - 1488

JO - Cancer Cell

JF - Cancer Cell

IS - 9

ER -

Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this